Fennec Pharmaceuticals Inc
SWB:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
SWB:RV41
|
US |
|
Endesa SA
MAD:ELE
|
ES |
|
Leon's Furniture Ltd
TSX:LNF
|
CA |
|
C
|
CDW Corp
XBER:CDW
|
US |
|
H
|
HALEON PLC
XHAM:H6D0
|
UK |
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
PAR:AI
|
FR |
|
G
|
Geron Corp
LSE:0IV3
|
US |
|
I
|
IHI Corp
SWB:IWJ
|
JP |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 15.24 EUR with a low forecast of 13.67 EUR and a high forecast of 17.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
15.24
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 15.24 EUR with a low forecast of 13.67 EUR and a high forecast of 17.76 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Revenue over the next 8 years is 24%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.